JNJ 📈 Johnson & Johnson - Overview

Johnson & Johnson operates as a multinational healthcare company, leveraging its subsidiaries to research, develop, manufacture, and sell a diverse range of products worldwide. The company's Innovative Medicine segment is focused on addressing various therapeutic areas, including immunology, where it offers treatments for conditions such as rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease. Additionally, this segment provides products for infectious diseases like HIV/AIDS, neuroscience treatments for mood disorders and neurodegenerative disorders, oncology treatments for prostate cancer and lung cancer, and cardiovascular and metabolism products to treat thrombosis and diabetes. These products are distributed through a network of retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.

The company's MedTech segment offers a broad portfolio of products, including Interventional Solutions such as electrophysiology products to treat heart rhythm disorders, and a heart recovery portfolio that includes technologies to treat severe coronary artery disease. This segment also provides neurovascular care products to treat hemorrhagic and ischemic stroke, as well as an orthopaedics portfolio that supports hips, knees, trauma, spine, sports, and other areas. Furthermore, the MedTech segment offers surgery portfolios comprising advanced and general surgery technologies, solutions for breast aesthetics, ear, nose, and throat procedures, and a range of contact lenses under the ACUVUE Brand. The company also manufactures TECNIS intraocular lenses for cataract surgery, distributing these products to a wide range of customers, including wholesalers, hospitals, and retailers, as well as physicians, nurses, and eye care professionals.

Johnson & Johnson has established a collaboration agreement with Stand Up To Cancer to research the use of a combination of teclistamab and daratumumab in treating a rare disease known as AL amyloidosis. With a history dating back to 1886, the company is headquartered in New Brunswick, New Jersey, and is listed on the New York Stock Exchange under the ticker symbol JNJ. The company's common stock is classified under the GICS Sub Industry of Pharmaceuticals, with the ISIN code US4781601046. More information about Johnson & Johnson can be found on its website at https://www.jnj.com.